Vivos Therapeutics (VVOS) News Today $2.40 -0.08 (-3.23%) (As of 07/26/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 November 2021 October 2021 September 2021 August 2021 Time Period June 27, 2024 | proactiveinvestors.comVivos Therapeutics reports positive results from pilot of provider-based modelJune 27, 2024 | globenewswire.comVivos Therapeutics Announces Positive Results From 7-Month Multi-Site Pilot of its New Provider-Based Marketing and Distribution ModelJune 12, 2024 | proactiveinvestors.comVivos Therapeutics announces strategic alliance and $7.5M investmentJune 12, 2024 | globenewswire.comVivos Therapeutics Closes $7.5 Million At-The-Market Private Equity-Backed Investment and Launches Strategic Marketing and Distribution AllianceMay 19, 2024 | msn.comVivos Therapeutics, Inc. (NASDAQ:VVOS) Q1 2024 Earnings Call TranscriptMay 15, 2024 | msn.comVivos Therapeutics GAAP EPS of -$1.63, revenue of $3.4MMay 15, 2024 | finance.yahoo.comVivos Therapeutics Inc (VVOS) Q1 2024 Earnings Call Transcript Highlights: Navigating ...May 14, 2024 | investorplace.comVVOS Stock Earnings: Vivos Therapeutics Reported Results for Q1 2024May 14, 2024 | proactiveinvestors.comVivos Therapeutics reports first quarter cost savings, launches revenue-generating initiativeMay 14, 2024 | globenewswire.comVivos Therapeutics Reports First Quarter 2024 Financial Results and Provides Operational UpdateMay 14, 2024 | globenewswire.comVivos Therapeutics Schedules Release of First Quarter 2024 Financial Results and Conference CallApril 11, 2024 | proactiveinvestors.comVivos Therapeutics expects increased adoption of oral medical devices following Medicare reimbursement approvalApril 9, 2024 | finance.yahoo.comVivos Therapeutics receives approval for Medicare reimbursement for flagship Oral Medical DevicesApril 9, 2024 | markets.businessinsider.comVivos Gets Approval To Facilitate Full Medicare Reimbursement For CARE Sleep Apnea Oral DevicesApril 9, 2024 | msn.comWhat's Going On With Vivos Therapeutics Stock?April 9, 2024 | msn.comMedicare to reimburse for Vivos CARE sleep apnea devicesApril 9, 2024 | proactiveinvestors.comVivos Therapeutics CARE oral medical devices approved for Medicare reimbursementApril 9, 2024 | investorplace.comWhy Is Vivos Therapeutics (VVOS) Stock Up 16% Today?April 9, 2024 | msn.comVivos Therapeutics files to sell 1.73M shares of common stock for holdersApril 9, 2024 | finance.yahoo.comVivos Therapeutics’ Flagship CARE Oral Medical Devices Receive Full Approval for Medicare ReimbursementApril 9, 2024 | globenewswire.comVivos Therapeutics' Flagship CARE Oral Medical Devices Receive Full Approval for Medicare ReimbursementApril 1, 2024 | proactiveinvestors.comVivos Therapeutics highlights path to cash flow positivity after FDA clearanceMarch 31, 2024 | finance.yahoo.comVivos Therapeutics Full Year 2023 Earnings: Misses ExpectationsMarch 30, 2024 | seekingalpha.comVivos Therapeutics, Inc. (VVOS) Q4 2023 Earnings Call TranscriptMarch 29, 2024 | marketwatch.comVivos Therapeutics Shares Fall After Wider-Than-Expected 4Q LossMarch 28, 2024 | globenewswire.comVivos Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Operational UpdateMarch 28, 2024 | globenewswire.comVivos Therapeutics Schedules Release of Fourth Quarter and Full Year 2023 Financial Results and Conference CallFebruary 22, 2024 | benzinga.comVivos Therapeutics Stock (NASDAQ:VVOS), Short Interest ReportFebruary 22, 2024 | benzinga.comVivos Therapeutics Stock (NASDAQ:VVOS) Insider TradesFebruary 18, 2024 | investing.comVivos Therapeutics secures $4 million through warrant exerciseFebruary 15, 2024 | finance.yahoo.comVivos Therapeutics Announces Exercise of Warrants for Approximately $4.0 Million Aggregate Gross ProceedsFebruary 15, 2024 | proactiveinvestors.comVivos Therapeutics sees gross proceeds of $4M from exercise of warrantFebruary 12, 2024 | finance.yahoo.comVivos Therapeutics CEO Kirk Huntsman Discusses FDA Approval and Market DisruptionsFebruary 6, 2024 | finanznachrichten.deVivos Therapeutics, Inc: Vivos Therapeutics Highlights Significant Favorable Market Developments Creating Exciting New Growth OpportunitiesFebruary 6, 2024 | finance.yahoo.comVivos Therapeutics Highlights Significant Favorable Market Developments Creating Exciting New Growth OpportunitiesJanuary 8, 2024 | finance.yahoo.comVivos Therapeutics Sees Positive Preliminary Metrics Following Unprecedented FDA 510(k) Clearance of the Company’s Proprietary Oral Medical Devices to Treat Severe OSADecember 18, 2023 | marketbeat.comTrading was temporarily halted for "VVOS" at 02:12 PM with a stated reason of "LULD pause." Trading set to resume at 02:12 PM. December 11, 2023 | proactiveinvestors.comVivos Therapeutics announces women-led airway health eventDecember 11, 2023 | finance.yahoo.comVivos Therapeutics Presents Groundbreaking Event: “Empowering Women to Champion Airway”December 4, 2023 | marketbeat.comBlack Swan: this small cap surged over 1000% last weekVivos Therapeutics experienced a rare 'black swan' event, surging over 1000% in a single day following breaking news, here's how to look at VVOS stock nowDecember 1, 2023 | proactiveinvestors.comVivos Therapeutics severe sleep apnea treatment’s a ‘breakthrough’, says CEONovember 30, 2023 | benzinga.comThinking about buying stock in Minim Inc, Walmart, Farfetch Ltd, Qualcomm, or Vivos Therapeutics Inc?November 30, 2023 | investorplace.comWhy Is Vivos Therapeutics (VVOS) Stock Down 35% Today?November 30, 2023 | msn.comPhilips shares slump as FDA says sleep product may overheatNovember 29, 2023 | proactiveinvestors.comVivos Therapeutics: Who is the medical device company creating frenzy in the markets?November 29, 2023 | marketbeat.comTrading was temporarily halted for "VVOS" at 03:11 PM with a stated reason of "LULD pause."November 29, 2023 | marketbeat.comTrading was temporarily halted for "VVOS" at 03:11 PM with a stated reason of "LULD pause." Trading set to resume at 03:11 PM. November 29, 2023 | marketbeat.comTrading was temporarily halted for "VVOS" at 03:11 PM with a stated reason of "LULD pause."November 29, 2023 | marketbeat.comTrading was temporarily halted for "VVOS" at 03:11 PM with a stated reason of "LULD pause."November 29, 2023 | marketbeat.comTrading was temporarily halted for "VVOS" at 03:11 PM with a stated reason of "LULD pause." Get Vivos Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for VVOS and its competitors with MarketBeat's FREE daily newsletter. Email Address New trading system called MSFT, NVDA & MSFT (Ad)Look 2023 kind of sucked from a trading standpoint… Despite the market finishing 24% higher…. Just seven stocks did all of the work… Unless you were holding or actively trading those 7 stocks, your trading year probably wasn’t as fruitful as you had hoped… According to my research, my new trading system would have spotted all seven of the “Magnificent stocks” MONTHS before they reached the highs they are trading at today. Just follow this link here! VVOS Media Mentions By Week VVOS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. VVOS News Sentiment▼1.430.62▲Average Medical News Sentiment VVOS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. VVOS Articles This Week▼22▲VVOS Articles Average Week Get Vivos Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for VVOS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Spectral AI News Today Beyond Air News Today Meihua International Medical Technologies News Today Femasys News Today SeaStar Medical News Today NeuroOne Medical Technologies News Today Nephros News Today Autonomix Medical News Today Carmell News Today GBS News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:VVOS) was last updated on 7/26/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredWe recommended Nvidia in 2016, now we’re recommending this…The AI boom is just getting started. And the real wealth has still to be made…Porter & Company | SponsoredNEW AI developed by trader who won 1,129% (in 2 days)Earlier this year one legendary trader captured a 1,129% win (in just 2 days) ... LIVE in front of thousands o...Monument Traders Alliance | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock (June 12) This $2 trillion D.C. shock i...Timothy Sykes | SponsoredGrab a pen and write down this ticker - here's whyA megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredBrace Yourself: Experts calling for Bitcoin to hit $100kFor the past few months, Bitcoin has been trading flat… It's been stuck around the $60,000 to $72,000 range...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vivos Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vivos Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free VVOS Stock Alerts